Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MAZE stock hub

Maze Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MAZEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.4B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MAZE

In the news

Latest news · MAZE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-47.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-510

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MAZE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001842295
Company name	Maze Therapeutics, Inc.
Country	United States
Country code	US
Cusip	578784100
Employees	141
Employees Change	16%
Employees Change Percent	12.8
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2025-01-31
Isin	US5787841007
Last refreshed	2026-05-10
Market cap	$1.4B
Market cap category	Small-Cap
Price	$26.03
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	MAZE
Website	https://www.mazetx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.11%
EV Sales Forward	96.15x
FCF yield	-7.83%
P/B ratio	3.62x
PS Forward	123.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-131.1M
Net Income Growth Years	0%
Profit Per Employee	$-929,929
ROA	-28.01
ROCE	-38.15
ROE	-47.52
ROIC	-510

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	174.48%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$397.1M
Cash	$341.9M
Current Assets	$349.7M
Current Liabilities	$22.6M
Debt	$23.3M
Debt Equity	$0.07
Equity	$355M
Liabilities	$42.2M
Long Term Assets	$47.4M
Long Term Liabilities	$19.6M
Net Cash	$318.6M
Net Cash By Market Cap	$22.13
Net Cash Growth	87.22%
Net Debt Equity	$-0.9
Tangible Book Value	$355M
Tangible Book Value Per Share	$7.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.5
Net Working Capital	$-10M
Quick ratio	15.23
Working Capital	$327.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,474.04%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	174.29%
200-day SMA	32.29
50-day SMA	34.95
50-day SMA vs 200-day SMA	50over200
All Time High	53.65
All Time High Change	-51.48%
All Time High Date	2026-03-16
All Time Low	6.71
All Time Low Change	287.93%
All Time Low Date	2025-04-09
ATR	1.84
Beta1y	0.66
Beta2y	0.96
Ch YTD	-37.17
High	26.25
High52	53.65
High52 Date	2026-03-16
High52ch	-51.48%
Low	25.13
Low52	8.25
Low52 Date	2025-05-15
Low52ch	215.71%
Ma50ch	-25.53%
Price vs 200-day SMA	-19.4%
RSI	36.41
RSI Monthly	45.34
RSI Weekly	38.46
Sharpe ratio	1.47x
Sortino ratio	2.69
Total Return	-1,474.04%
Tr YTD	-37.17
Tr1m	-8.12%
Tr1w	-4.2%
Tr3m	-42.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	4
Analyst Price Target Top	$56.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.59
Earnings Revenue Estimate	10,050,000x
Operating Income	$-142.9M
Price target	$68.25
Price Target Change	$162
Price Target Change Top	$117

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,281,607%
Float Percent	60.19%
Shares Insiders	1.1%
Shares Institutions	56.1%
Shares Out	55,298,584
Shares Qo Q	16.64%
Shares Yo Y	1,474.04%
Short Float	11.41%
Short Ratio	2.78
Short Shares	6.86

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-129.1M
Average Volume	831,489x
Bv Per Share	7.2
CAPEX	$-794,000
Ch1m	-8.12
Ch1w	-4.2
Ch1y	174.3
Ch3m	-42.19
Ch6m	-8.99
Change	2.2%
Change From Open	2.28
Close	25.47
Days Gap	-0.08
Depreciation Amortization	2,403,000
Dollar Volume	13,925,399.3
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-142.9M
EBITDA	$-140.5M
EPS	$-3.05
F Score	2
FCF	$-112.7M
FCF EV Yield	-10.06x
FCF Per Share	$-2.04
Financing CF	275,337,000
Fiscal Year End	December
Founded	2,018
Investing CF	-170,962,000
Ipr	62.69
Iprfo	61.48
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-25
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-25
Ma150	37.12
Ma150ch	-29.88%
Ma20	26.55
Ma20ch	-1.97%
Net CF	-7,565,000
Next Earnings Date	2026-05-22
Open	25.45
Optionable	Yes
Position In Range	80.36
Post Close	26.03
Postmarket Change Percent	0.23
Postmarket Price	$26.09
Ppne	25,160,000
Price Date	2026-05-08
Ptbv Ratio	4.06
Relative Volume	0.64x
Share Based Comp	16,400,000
Tr6m	-8.99%
Us State	California
Volume	534,975

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MAZE pay a dividend?

Capital-return profile for this ticker.

Performance

MAZE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MAZE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+56.1%

Float: +60.2% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MAZE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.4

Neutral momentum band

Price vs 200-day MA

-19.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.47

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MAZE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MAZE stock rating?

Maze Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MAZE analysis?

The full report lives at /stocks/MAZE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MAZE?

The latest report frames MAZE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MAZE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.